SGIOF (Shionogi) Cyclically Adjusted Revenue per Share: $0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGIOF Shionogi & Co Ltd SGIOF
82 GF Score
Price $17.45
GF Value $17.74
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Shionogi Cyclically Adjusted Revenue per Share?

Shionogi SGIOF -0.57% 82 Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2026. GuruFocus rates SGIOF with a GF Score™ of 82/100 and a GF Value™ of $17.74 (Fairly Valued). The stock has 2 warning signs investors should review.

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shionogi's adjusted revenue per share for the three months ended in Jun. 2026 was $1.194. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Shionogi's average Cyclically Adjusted Revenue Growth Rate was 6.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Shionogi was 8.30% per year. The lowest was 2.40% per year. And the median was 3.95% per year.

As of today (2026-08-06), Shionogi's current stock price is $17.45. Shionogi's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $0.00. Shionogi's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shionogi was 8.40. The lowest was 4.61. And the median was 6.25.


Shionogi  (OTCPK:SGIOF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shionogi was 8.40. The lowest was 4.61. And the median was 6.25.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shionogi Cyclically Adjusted Revenue per Share Related Terms


Shionogi Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Shionogi's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shionogi Cyclically Adjusted Revenue per Share Chart

Shionogi Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.79 2.82 2.54 2.95 2.65

Shionogi Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.04 3.25 2.43 2.65 0.00

SGIOF vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shionogi Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shionogi's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shionogi's Cyclically Adjusted PS Ratio falls into.


SGIOF
82GF Score
Shionogi & Co Ltd SGIOF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shionogi Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shionogi's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.194/113.6000*113.6000
=1.194

Current CPI (Jun. 2026) = 113.6000.

Shionogi Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.812 98.000 0.941
201612 0.894 98.400 1.032
201703 0.751 98.100 0.870
201706 0.696 98.500 0.803
201709 0.903 98.800 1.038
201712 0.832 99.400 0.951
201803 0.800 99.200 0.916
201806 0.840 99.200 0.962
201809 0.744 99.900 0.846
201812 0.921 99.700 1.049
201903 0.988 99.700 1.126
201906 0.799 99.800 0.909
201909 0.824 100.100 0.935
201912 0.902 100.500 1.020
202003 0.799 100.300 0.905
202006 0.728 99.900 0.828
202009 0.784 99.900 0.892
202012 0.791 99.300 0.905
202103 0.736 99.900 0.837
202106 0.692 99.500 0.790
202109 0.764 100.100 0.867
202112 0.724 100.100 0.822
202203 1.077 101.100 1.210
202206 0.593 101.800 0.662
202209 0.611 103.100 0.673
202212 1.568 104.100 1.711
202303 0.748 104.400 0.814
202306 0.876 105.200 0.946
202309 0.933 106.200 0.998
202312 0.852 106.800 0.906
202403 0.753 107.200 0.798
202406 0.727 108.200 0.763
202409 0.957 108.900 0.998
202412 0.914 110.700 0.938
202503 0.825 111.100 0.844
202506 0.812 111.700 0.826
202509 0.899 112.000 0.912
202512 1.114 113.000 1.120
202603 1.029 112.700 1.037
202606 1.194 113.600 1.194

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
Shionogi (SGIOF) has a Cyclically Adjusted Revenue per Share of $0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shionogi and its competitors.
Is Shionogi's Cyclically Adjusted Revenue per Share too high?
Shionogi's current Cyclically Adjusted Revenue per Share is $0.00. Overall, Shionogi has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shionogi's Cyclically Adjusted Revenue per Share compare to ZTS?
Shionogi's Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shionogi and its competitors. Shionogi's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shionogi stock overvalued right now?
Based on GuruFocus' analysis, Shionogi (SGIOF) is currently considered Fairly Valued. The stock's GF Value™ is $17.74, compared to a current price of $17.45 — trading 1.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.00. Shionogi's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Shionogi (SGIOF), the current Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shionogi (SGIOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shionogi stock appears to be undervalued. The current stock price of $17.45 is trading 1.6% below its estimated GF Value™ of $17.74. GuruFocus considers Shionogi to be Fairly Valued.

Key valuation signals for SGIOF:

  • Cyclically Adjusted Revenue per Share: $0.00
  • GF Value™: $17.74 vs. price of $17.45 (1.6% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the SGIOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shionogi Business Description

Address 3-1-8 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. The company engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late-stage drug discovery through commercial production. It provides products and services in Japan, Europe, North America, and other regions.
82GF Score

Get the complete analysis for SGIOF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.45
Price
$17.74
GF Value